These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 12677364

  • 21. Reduced intrapatient variability of cyclosporine pharmacokinetics in renal transplant recipients switched from oral Sandimmune to Neoral.
    Mendez R, Abboud H, Burdick J, Copley B, Freeman R, Batiuk TD, Cooney GF, Barbeito R.
    Clin Ther; 1999 Jan; 21(1):160-71. PubMed ID: 10090433
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
    Brunet M, Crespo M, Millán O, Serón D, Torregrosa V, Jiménez O, Moreso F, Martorell J, Grinyo JM, Oppenheimer F.
    Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
    [Abstract] [Full Text] [Related]

  • 24. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
    Lück R, Böger J, Kuse E, Klempnauer J, Nashan B.
    Liver Transpl; 2004 May; 10(5):686-91. PubMed ID: 15108262
    [Abstract] [Full Text] [Related]

  • 25. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile.
    Takeda A, Horike K, Onoda H, Ohtsuka Y, Yoshida A, Uchida K, Morozumi K.
    Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study.
    Kyllönen LE, Salmela KT.
    Transplantation; 2006 Apr 15; 81(7):1010-5. PubMed ID: 16612277
    [Abstract] [Full Text] [Related]

  • 28. A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients.
    Mathias HC, Ozalp F, Will MB, Borland W, Payne C, Kerr M, Lockhart J, Murday AJ.
    J Heart Lung Transplant; 2005 Dec 15; 24(12):2137-43. PubMed ID: 16364862
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. C2 monitoring of cyclosporine in de novo liver transplant recipients: the clinician's perspective.
    Villamil F, Pollard S.
    Liver Transpl; 2004 May 15; 10(5):577-83. PubMed ID: 15108248
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.
    Kahan BD, Dunn J, Fitts C, Van Buren D, Wombolt D, Pollak R, Carson R, Alexander JW, Choc M, Wong R.
    Transplantation; 1995 Feb 27; 59(4):505-11. PubMed ID: 7878754
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D, Noppakun K, Rojanasthien N, Kanchanarattanakorn K, Jittikanont S, Manoyot A, Bunnachak D, Ophascharoensuk V.
    J Med Assoc Thai; 2006 Aug 27; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [Abstract] [Full Text] [Related]

  • 35. Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Barkholt L, Remberger M, Bodegård H, Ringdén O, Böttiger Y.
    Bone Marrow Transplant; 2007 Oct 27; 40(7):683-9. PubMed ID: 17660840
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
    Strong DK, Lai A, Primmett D, White CT, Lirenman DS, Carter JE, Hurley RM, Virji M, Ensom MH.
    Pediatr Transplant; 2005 Oct 27; 9(5):566-73. PubMed ID: 16176411
    [Abstract] [Full Text] [Related]

  • 40. Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patients.
    Li J, Dahmen U, Beckebaum S, Cicinnati V, Valentin-Gamazo C, Frilling A, Malago M, Broelsch CE.
    Eur J Med Res; 2006 Apr 28; 11(4):139-45. PubMed ID: 16720277
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.